Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01408485 · ClinicalTrials.gov registry record · NA
Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT01408485 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 200 participants.
The verdict
NCT01408485, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
To demonstrate that ablation with the Therapy™ Cool Flex™ Irrigated Ablation System is effective in the treatment of typical atrial flutter (cavo-tricuspid dependent) and that its use does not result in an unacceptable risk of intra-procedural, serious cardiac adverse events.
Interventions
- DEVICE Therapy™ Cool Flex™ Irrigated Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01408485
The ClinicalTrials.gov registry entry for NCT01408485 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Therapy™ Cool Flex™ Irrigated Ablation System is the first listed.
NCT01408485 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01408485 about?
NCT01408485 is a clinical study titled "Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter". To demonstrate that ablation with the Therapy™ Cool Flex™ Irrigated Ablation System is effective in the treatment of typical atrial flutter (cavo-tricuspid dependent) and that its use does not result in an unacceptable risk of intra-procedural, serious cardiac adverse events.
What is the current status of trial NCT01408485?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2011-11. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01408485?
The interventions under investigation include: Therapy™ Cool Flex™ Irrigated Ablation System (DEVICE).
Who is sponsoring clinical trial NCT01408485?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.